Targeted steroid-sparing therapies and structured exercise programs are transforming the clinical management of inflammatory ...

Patients with Sjögren disease and lymphoid interstitial pneumonia may present with a distinct clinical phenotype and preserved pulmonary function.

In adults with type 2 diabetes, use of GLP-1 receptor agonists is associated with an increased risk for incident nonscarring alopecia.

An overview of 5 FDA Priority Review PDUFA decision dates in September 2026, covering novel treatments in rare neurological disorders, oncology, and adolescent cardiology.

Routine add-on oral antihistamines offer no meaningful clinical benefit for managing atopic dermatitis in children and adults.

Significant disproportionality signals have been identified for adverse drug events (ADEs) linked to apremilast, according to study results published in Experimental Dermatology.

Healthy plant-based diets are associated with lower CVD, T2D, and mortality risks regardless of food processing levels.

Regardless of patient ethnicity or socioeconomic status, disease activity improved over 6 months after the initiation of a tumor necrosis factor inhibitor for juvenile idiopathic arthritis.

Higher body mass index is linked to reduced odds of achieving minimal disease activity in psoriatic arthritis.

Vunakizumab provides rapid and sustained clinical improvement in plaque psoriasis regardless of disease duration or baseline disease severity.

Ultra-high frequency ultrasound of the labial salivary glands may accurately classify Sjögren disease and reduce the need for biopsy.

A unified, consensus-driven framework for lupus nephritis outcomes is essential to improve trial interpretability, personalize therapy, and ultimately enhance renal outcomes.